(S)-2,2-Dimethylchroman-4-amine is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its chiral structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting the central nervous system. It is often employed in the production of compounds with potential antidepressant, anxiolytic, or neuroprotective properties. Additionally, its unique scaffold is explored in medicinal chemistry for designing molecules with enhanced selectivity and efficacy in drug discovery programs.